Therefore, in this study, we isolated CD24−/low/CD44+ cells from RT-R-MDA-MB-231 cells and determined the role of these CSCs in RT-R-TNBC on tumor progression and immune evasion. The gene discussed is CD44; the disease is neoplasm.